- Home
- ALLO vs FRGE Comparison
ALLO vs FRGE Comparison
Compare ALLO & FRGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALLO
- FRGE
- Stock Information
- Founded
- ALLO 2017
- FRGE 2014
- Country
- ALLO United States
- FRGE United States
- Employees
- ALLO N/A
- FRGE N/A
- Industry
- ALLO Biotechnology: Biological Products (No Diagnostic Substances)
- FRGE Computer Software: Prepackaged Software
- Sector
- ALLO Health Care
- FRGE Technology
- Exchange
- ALLO Nasdaq
- FRGE Nasdaq
- Market Cap
- ALLO 231.9M
- FRGE 262.8M
- IPO Year
- ALLO 2018
- FRGE N/A
- Fundamental
- Price
- ALLO $1.11
- FRGE $17.70
- Analyst Decision
- ALLO Strong Buy
- FRGE Buy
- Analyst Count
- ALLO 10
- FRGE 5
- Target Price
- ALLO $8.88
- FRGE $35.50
- AVG Volume (30 Days)
- ALLO 3.8M
- FRGE 91.9K
- Earning Date
- ALLO 11-06-2025
- FRGE 11-05-2025
- Dividend Yield
- ALLO N/A
- FRGE N/A
- EPS Growth
- ALLO N/A
- FRGE N/A
- EPS
- ALLO N/A
- FRGE N/A
- Revenue
- ALLO N/A
- FRGE $90,840,000.00
- Revenue This Year
- ALLO N/A
- FRGE $32.56
- Revenue Next Year
- ALLO $100.00
- FRGE $21.75
- P/E Ratio
- ALLO N/A
- FRGE N/A
- Revenue Growth
- ALLO N/A
- FRGE 14.78
- 52 Week Low
- ALLO $0.86
- FRGE $6.60
- 52 Week High
- ALLO $3.78
- FRGE $24.90
- Technical
- Relative Strength Index (RSI)
- ALLO 44.66
- FRGE 41.16
- Support Level
- ALLO $1.06
- FRGE $16.90
- Resistance Level
- ALLO $1.18
- FRGE $18.22
- Average True Range (ATR)
- ALLO 0.08
- FRGE 0.89
- MACD
- ALLO 0.01
- FRGE -0.28
- Stochastic Oscillator
- ALLO 31.25
- FRGE 25.14
About ALLO Allogene Therapeutics Inc.
Allogene Therapeutics Inc is a clinical-stage biotech firm specializing in immuno-oncology, focusing on the development of genetically engineered allogeneic T-cell products for cancer and autoimmune diseases. Their pipeline includes off-the-shelf T-cell candidates designed to target cancer cells or autoreactive cells in autoimmune disorders. Notably, their allogeneic approach, derived from healthy donors, allows for broader patient eligibility and scalability. With a vision to redefine CAR T therapy, the company concentrates on core programs targeting lymphoma, leukemia, autoimmune diseases, and solid tumors. Revenue, generated from collaborations and licensing agreements, supports their research and development efforts.
About FRGE Forge Global Holdings Inc.
Forge Global Holdings Inc is a financial service platform created to serve the needs of the private market. It provides marketplace infrastructure, data services, and technology solutions for private market participants. The company offers a trusted trading platform, proprietary data and insights to inform investment strategies, along with custody services to help companies, shareholders, institutions and accredited investors confidently navigate and transact in the private market.